Mehdi Farhangi
- Co-authors
- Elliott F. OssermanGiampaolo MerliniHenry O. HeinemannFranco M. MuggiaL.R.G. ValadonAli KhojastehAlan M. LugerAlan M. Solinger
- Topics
- Multiple Myeloma Research and Treatments (4 papers)Chronic Lymphocytic Leukemia Research (2 papers)Platelet Disorders and Treatments (2 papers)
- Cited by
- HematologyGeneticsNephrology
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Mehdi Farhangi
17 papers receiving 321 citations
Peers
Comparison fields: 5 of 62
- Molecular Biology 126
- Hematology 112
- Genetics 82
- Pulmonary and Respiratory Medicine 55
- Oncology 47
Countries citing papers authored by Mehdi Farhangi
This map shows the geographic impact of Mehdi Farhangi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehdi Farhangi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehdi Farhangi more than expected).
Fields of papers citing papers by Mehdi Farhangi
This network shows the impact of papers produced by Mehdi Farhangi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehdi Farhangi. The network helps show where Mehdi Farhangi may publish in the future.
Co-authorship network of co-authors of Mehdi Farhangi
This figure shows the co-authorship network connecting the top 25 collaborators of Mehdi Farhangi. A scholar is included among the top collaborators of Mehdi Farhangi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mehdi Farhangi. Mehdi Farhangi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | Carboplatin, etoposide, and bleomycin for treatment of stage IIC seminoma complicated by acute renal failure. | 3 |
| 3 | 0 | |
| 4 | The clinical implications of monoclonal immunoglobulins. | 31 |
| 5 | Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias. | 68 |
| 6 | 12 | |
| 7 | 9 | |
| 8 | 5 | |
| 9 | 9 | |
| 10 | 6 | |
| 11 | 17 | |
| 12 | 23 | |
| 13 | 13 | |
| 14 | 42 | |
| 15 | The treatment of multiple myeloma. | 32 |
| 16 | 2 | |
| 17 | 90 | |
| 18 | 2 |
About Mehdi Farhangi
Mehdi Farhangi is a scholar working on Hematology, Genetics and Nephrology, having authored 18 papers that have together received 373 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Hematology (112 citations), Genetics (82 citations) and Nephrology (29 citations). Mehdi Farhangi has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Elliott F. Osserman, Giampaolo Merlini, Henry O. Heinemann, Franco M. Muggia, L.R.G. Valadon, Ali Khojasteh, Alan M. Luger, Alan M. Solinger, Michael C. Perry and Thomas M. O’Dorisio. Their work appears in journals such as New England Journal of Medicine, The American Journal of Medicine and Journal of Food Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.